Pathogenic role of 25-hydroxycholesterol in cancer development and progression

  • Sura Salman Ejam
  • , Raed Obaid Saleh
  • , Maria Jade Catalan Opulencia
  • , Mazin A.A. Najm
  • , Aziza Makhmudova
  • , Abduladheem Turki Jalil
  • , Walid Kamal Abdelbasset
  • , Moaed E. Al-Gazally
  • , Ali Thaeer Hammid
  • , Yasser Fakri Mustafa
  • , Sergushina Elena Sergeevna
  • , Sajad Karampoor
  • , Rasoul Mirzaei

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

Cholesterol is an essential lipid that serves several important functions, including maintaining the homeostasis of cells, acting as a precursor to bile acid and steroid hormones and preserving the stability of membrane lipid rafts. 25-hydroxycholesterol (25-HC) is a cholesterol derivative that may be formed from cholesterol. 25-HC is a crucial component in various biological activities, including cholesterol metabolism. In recent years, growing evidence has shown that 25-HC performs a critical function in the etiology of cancer, infectious diseases and autoimmune disorders. This review will summarize the latest findings regarding 25-HC, including its biogenesis, immunomodulatory properties and role in innate/adaptive immunity, inflammation and the development of various types of cancer.

Original languageEnglish
Pages (from-to)4415-4442
Number of pages28
JournalFuture Oncology
Volume18
Issue number39
DOIs
StatePublished - 1 Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 25-HC
  • cancer
  • immunity
  • immunometabolism
  • inflammation

Fingerprint

Dive into the research topics of 'Pathogenic role of 25-hydroxycholesterol in cancer development and progression'. Together they form a unique fingerprint.

Cite this